Instil Historical Income Statement
| TIL Stock | USD 17.89 1.82 9.23% |
Historical analysis of Instil Bio income statement accounts such as Total Revenue of 0.0, Other Operating Expenses of 103.3 M, Research Development of 9.5 M or Cost Of Revenue of 3.7 M can show how well Instil Bio performed in making a profits. Evaluating Instil Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Instil Bio's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Instil Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Instil Bio is a good buy for the upcoming year.
Instil |
About Instil Income Statement Analysis
Instil Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Instil Bio shareholders. The income statement also shows Instil investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Instil Bio Income Statement Chart
Add Fundamental
Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Cost Of Revenue
Cost of Revenue is found on Instil Bio income statement and represents the costs associated with goods and services Instil Bio provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Instil Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Instil Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.At this time, Instil Bio's Interest Expense is quite stable compared to the past year. Other Operating Expenses is expected to rise to about 103.3 M this year, although the value of Net Interest Income is projected to rise to (1.9 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Depreciation And Amortization | 6.0M | 4.8M | 3.6M | 3.2M | Interest Income | 3.7M | 8.5M | 7.0M | 3.5M |
Instil Bio income statement Correlations
Click cells to compare fundamentals
Instil Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Instil Bio income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Tax Provision | 151K | 39K | (2.1M) | (605K) | (544.5K) | (571.7K) | |
| Net Interest Income | 70K | 3.8M | 1.8M | 4.5M | (2.0M) | (1.9M) | |
| Interest Income | 70K | 80K | 3.7M | 8.5M | 7.0M | 3.5M | |
| Depreciation And Amortization | 256K | 2.8M | 6.0M | 4.8M | 3.6M | 3.2M | |
| Interest Expense | 3.3M | 1.6M | 1.9M | 5.2M | 8.0M | 8.4M | |
| Selling General Administrative | 14.4M | 48.3M | 62.2M | 47.6M | 44.2M | 40.2M | |
| Gross Profit | 138K | (2.8M) | (6.0M) | (4.8M) | (4.3M) | (4.5M) | |
| Other Operating Expenses | 33.8M | 155.6M | 203.3M | 90.5M | 73.5M | 103.3M | |
| Operating Income | (33.6M) | (155.6M) | (226.5M) | (90.5M) | (73.5M) | (77.2M) | |
| Net Income From Continuing Ops | (37.7M) | (156.8M) | (223.2M) | (197.0M) | (74.1M) | (77.8M) | |
| Ebit | (33.6M) | (155.6M) | (223.4M) | (150.9M) | (66.1M) | (69.4M) | |
| Research Development | 19.4M | 107.3M | 141.1M | 43.0M | 10M | 9.5M | |
| Ebitda | (33.4M) | (152.8M) | (217.4M) | (146.1M) | (62.5M) | (65.7M) | |
| Total Operating Expenses | 33.8M | 155.6M | 203.3M | 85.8M | 73.5M | 102.4M | |
| Reconciled Depreciation | 256K | 2.8M | 6.0M | 5.8M | 3.6M | 3.4M | |
| Income Before Tax | (37.6M) | (156.8M) | (225.3M) | (156.1M) | (74.1M) | (77.8M) | |
| Total Other Income Expense Net | (3.9M) | (1.2M) | 1.2M | (65.5M) | (594K) | (623.7K) | |
| Net Income | (37.7M) | (156.8M) | (223.2M) | (156.1M) | (74.1M) | (77.8M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.